Reimagine Food is the world's first disruptive innovation centre dedicated to the food of the future, which has just announced the launch of a new fund for FoodTech companies to be launched next year.
The aim is for the fund to raise €100M from investors interested in participating in companies that could revolutionise the global food industry. The challenge is to raise 80% of capital from foreign investors. The rest would come from Spanish companies and Reimagine Food itself. "With 100M we will become the second European fund specialising in this sector, behind Terra Capital, which has a €128M vehicle for agri-food" says the co-founder of Reimagine Food.
Reimagine Food Ventures will take stakes in start-ups that already have some experience and have demonstrated the viability of their business model and require funds to finance their growth. Some of the 20 food-tech start-ups that Reimagine Food has accelerated in the last two years through the Prometheus programme, including US start-ups Impact Visión and Edamam and Catalan start-up Nu4Mat, could be among the investment targets of the vehicle. We are witnessing the uberisation of food: we are facing a scenario of radical and transformative change", says Robles.
K Fund came to the market on 17 October with €50M to invest in startups that may have a future in the international market. Beyond focusing on early-stage startups, the fund has a vision of co-investing with other venture capital funds in more advanced stages of the business.
At the moment, K Fund has three companies in its portfolio. Salupro, a company that supplies and compares prices of products to clinics in Madrid; Lucera, focused on energy management; and Hooks, a social app for live events. Over the next few years it plans to build a portfolio of 20-25 companies.
K fund, will back companies with amounts between EUR 100,000 and EUR 2 million, although they will also carry out follow-on rounds with a maximum investment of EUR 7.5 million.
Ysios Capital launched Ysios BioFund II Innvierte FCR, with a total amount of €126.4M, far exceeding the initial target of €100M.
Ysios BioFund II Innvierte will follow a similar investment strategy to its predecessor, Ysios BioFund I, which is currently in the divestment phase, investing mainly in Europe and with a particular focus on Spain. The fund will finance up to 15 companies in the life sciences sector, mainly in the start-up and development stages, developing disruptive products that represent a paradigm shift in the approach to disease. To this end, it will invest in companies in the field of new drugs, diagnostic systems and medical technologies.
Ysios BioFund II Innvierte has among its investors all the Family Offices that invested in Ysios BioFund I. It has also incorporated among its investors the CDTI, through its Innvierte programme, the European Investment Fund through InnovFin SME Venture Capital, pension funds such as Orza, Lagun Aro or Banco Sabadell (BIDSA), financial institutions and private investors.
If you are looking for investors, get in touch with us. Abra-invest has a team of experts in alternative financing at your disposal. Call + 34 946424142 or fill in the contact form.